Late-breaking data from Abbott's groundbreaking first-in-human study demonstrated successful implantation of the company's AVEIR Conduction System Pacing (CSP) leadless pacemaker Enrollment has also begun in the ASCEND CSP pivotal clinical trial to evaluate Abbott's investigational CSP...
Hence then, the article about abbott highlights new aveir data initiates trial for the company s conduction system pacing technology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology )
Also on site :
- Saudi Arabia to unify LPG gas cylinder prices nationwide from January 2026
- Two dozen killed in Ukrainian strike on Russian New Year’s celebration – governor
- Volunteer in Iran’s Revolutionary Guard reportedly killed during widening protests